Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MRVI | ABT | MDT | SYK | BSX |
| Company | Maravai Lifesciences Holdings Inc Cl A | Abbott Laboratories | Medtronic Inc | Stryker Corp | Boston Scientific Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 8.43 | 110.09 | 80.96 | 345.79 | 68.73 |
| High | 8.43 | 110.89 | 81.50 | 346.33 | 68.96 |
| Low | 8.07 | 108.83 | 79.87 | 337.97 | 67.40 |
| Last | 8.11 | 108.89 | 80.23 | 339.13 | 67.44 |
| Change | -0.29 | -0.22 | +0.10 | -2.92 | -0.63 |
| % Change | -3.45% | -0.20% | +0.12% | -0.85% | -0.93% |
| Volume | 1,707,600 | 4,595,600 | 7,500,200 | 1,087,700 | 6,527,100 |
| 20-Day Average Volume | 2,556,375 | 6,110,910 | 5,997,805 | 973,505 | 5,080,995 |
| Previous Close | 8.40 | 109.11 | 80.13 | 342.05 | 68.07 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.37 | 111.41 | 83.83 | 350.86 | 68.02 |
| 20-Day Raw Stochastic | 47.06% | 5.48% | 8.20% | 5.39% | 41.97% |
| 20-Day Relative Strength | 53.21% | 39.82% | 37.22% | 42.07% | 52.72% |
| Weighted Alpha | -50.67 | -0.67 | -6.35 | +16.45 | +35.92 |
| Today's Opinion | 40% Buy | 8% Buy | 8% Sell | 56% Buy | 88% Buy |
| Previous Opinion | 72% Buy | 24% Buy | 8% Sell | 56% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 24% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.05% since 04/08/24 | -1.47% since 04/08/24 | -3.23% since 04/08/24 | -3.04% since 04/08/24 | -1.82% since 04/08/24 |
| Low | 7.83 on 04/09/24 | 108.49 on 04/12/24 | 79.56 on 04/12/24 | 337.97 on 04/15/24 | 67.40 on 04/15/24 |
| High | 8.73 on 04/11/24 | 112.57 on 04/09/24 | 83.83 on 04/09/24 | 351.27 on 04/09/24 | 69.21 on 04/11/24 |
| 1-Month | |||||
| %Chg | +5.32% since 03/15/24 | -5.71% since 03/15/24 | -4.00% since 03/15/24 | -3.72% since 03/15/24 | +1.83% since 03/15/24 |
| Low | 7.39 on 03/18/24 | 108.49 on 04/12/24 | 79.56 on 04/12/24 | 337.97 on 04/15/24 | 66.16 on 03/18/24 |
| High | 8.92 on 04/04/24 | 115.76 on 03/18/24 | 87.73 on 03/28/24 | 359.50 on 03/28/24 | 69.21 on 04/11/24 |
| 3-Month | |||||
| %Chg | +24.58% since 01/12/24 | -4.42% since 01/12/24 | -8.22% since 01/12/24 | +8.38% since 01/12/24 | +12.51% since 01/12/24 |
| Low | 5.05 on 02/22/24 | 108.49 on 04/12/24 | 79.56 on 04/12/24 | 307.23 on 01/25/24 | 59.61 on 01/16/24 |
| High | 8.92 on 04/04/24 | 121.64 on 03/08/24 | 89.18 on 01/31/24 | 361.41 on 03/11/24 | 69.21 on 04/11/24 |
| 6-Month | |||||
| %Chg | +4.38% since 10/13/23 | +19.83% since 10/13/23 | +11.49% since 10/13/23 | +31.51% since 10/13/23 | +36.19% since 10/13/23 |
| Low | 4.52 on 11/09/23 | 90.87 on 10/16/23 | 68.84 on 10/30/23 | 255.22 on 10/26/23 | 49.15 on 10/27/23 |
| High | 8.92 on 04/04/24 | 121.64 on 03/08/24 | 89.18 on 01/31/24 | 361.41 on 03/11/24 | 69.21 on 04/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,111,760 | 189,325,920 | 106,398,448 | 130,139,760 | 99,865,216 |
| Shares Outstanding, K | 251,400 | 1,735,184 | 1,327,823 | 380,470 | 1,467,096 |
| Annual Sales | 288,950,000 | 40,109,000,000 | 31,227,000,000 | 20,498,000,000 | 14,240,000,000 |
| Annual Net Income | -119,030,000 | 5,723,000,000 | 3,758,000,000 | 3,165,000,000 | 1,591,000,000 |
| Last Quarter Sales | 74,140,000 | 10,241,000,000 | 8,089,000,000 | 5,815,000,000 | 3,725,000,000 |
| Last Quarter Net Income | -105,960,000 | 1,594,000,000 | 1,322,000,000 | 1,143,000,000 | 503,000,000 |
| 60-Month Beta | 0.01 | 0.74 | 0.76 | 0.89 | 0.78 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 02/22/24 | 1.19 on 01/24/24 | 1.30 on 02/20/24 | 3.46 on 01/30/24 | 0.55 on 01/31/24 |
| Latest Earnings Date | 05/08/24 | 04/17/24 | 05/23/24 | 04/30/24 | 04/24/24 |
| Most Recent Dividend | N/A | 0.550 on 04/12/24 | 0.690 on 03/21/24 | 0.800 on 03/27/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/12/24 | 03/21/24 | 03/27/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.57 | 15.06 | 32.27 | 33.20 |